Real-World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single-Center Prospective Study. Li Z, Wang Y, Wu Y, Yin H, et al. Allergy 2025 Feb 10. doi: 10.1111/all.16495.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Z, Wang Y, Wu Y, Yin H, et al. Real-World Efficacy and Safety of Abrocitinib in Chinese Atopic Dermatitis Patients: A Single-Center Prospective Study. Allergy 2025 Feb 10. doi: 10.1111/all.16495.
PMID: 39927851